Health

"The leading drug-industry trade group and the U.S. Chamber of Commerce are working ... to demonstrate the cost of depression in the workplace and to show employers that treating affected workers would improve the bottom line," reports The Hill.

"A whistleblower who uncovered evidence that major drug companies sought to influence government officials has been removed from his job and placed on administrative leave," reports Jeanne Lenzer. "Allen Jones, an investigator at the Pennsylvania Office of the Inspector General (OIG), was escorted out of his workplace on 28 April and told 'not to appear on OIG property' after OIG officials accused him of talking to the press. ...

The British medical journal The Lancet published a review of "six published and six unpublished trials" studying antidepressant use by children that concluded that, in most cases, "the risks exceeded the benefits." More disturbingly, the review found evidence that pharmaceutical companies "had been aware of problems but did not reveal them." In a memo leaked last month from GlaxoSmithKline, the company warn

Leslie Green at Stapleton Communications has a bachelor's degree in Marketing Communications from California Polytechnic State University, which must be where she learned how to stonewall reporters while still sounding upbeat. A detailed new investigative report charges her client, AXT Inc., with poisoning its workers with gallium arsenide, a potent carcinogen used to make semiconductors.